Erik Reinertsen

Product & Strategy @ Standard Model Bio

📍 United States🔄 Updated September 2026💼 1 investments📅 3 years investing🗓 Last invested Jan 2023
VC🌍 United States
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
3y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Advisor
2023
This is a catchall company for the doers, the thinkers, and the innovators.
Experience · 3 entries
All (3)
Investments (1)
Founder (1)
2023
Investor & Advisor
2023
This is a catchall company for the doers, the thinkers, and the innovators.
2018
Investment Team
2018
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. We are based alongside Takeda’s R&D site in Cambridge, MA. Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world. We invest in preclinical therapeutic platform opportunities that complement Takeda’s pipeline and products. Our mission is to create strategic growth opportunities for Takeda by investing and nurturing innovative Life Science Companies in areas aligned with Takeda’s R&D foci which include; Oncology, Gastroenterology/Inflammation, and Neuroscience.
2014
Co-Founder
2014
Forge was a non-profit organization that connected digital health startups with the Atlanta healthcare ecosystem. We raised $40K, organized the first two healthcare hackathons in Atlanta, connected founders to clinical investigators, and helped launch product pilots at Emory Healthcare and the Atlanta VA Medical Center. We sourced and worked with startups that went on to raise capital and/or exit: Memora Health (acquired), Radix Health (acquired), Movn Health ($20M series A), and Codoxo ($20M series B). In 2016 Forge merged with Sling Health.